Derivation Web

source_c679ada8ccc646f8

**Selected angle:** `boundary_condition`

## One-sentence thesis

Across 7 independently cited sources, the evidence converges on one bounded claim: sGLT2 inhibitors reduce the risk of cardiovascular death, heart failure hospitalization, and major adverse cardiovascular events in patients with type 2 diabetes and/or heart failure or CKD. Effect sizes vary by subgroup and are listed per source belo…